home Home > Reserch Institutes> Attached Organizations
Lee Gil Ya Cancer & Diabetes Institute (LCDI) has been producing outstanding research accomplishments including presentation of the first Korean genome sequence and analysis, development of the world's first cancer prognostic kit, and the discovery of an anti-obesity protein in the brain. LCDI operates Korea's first Mouse Metabolic Phenotyping Center (KMMPC), Center for the Research of Hereditary Hemorrhagic Telangiectasia, Genomics & Proteomics Center, and Animal Experiment Center.
Major Work  
1. Promote research on the immunological treatment of cancer, diagnosis of cancer, research on the occurring mechanism, prevention of cancer, and pediatric cancer
2. Research and develop treatments for a variety of metastatic and recurrent cancers
3. Perform state-of-the-art clinical and basic research on the diagnosis, cause, and preventive treatment of diabetes
4. Create community programs that provide the most up-to-date and innovative training, support, examinations and treatments for diabetes patients of all ages.